阿比拉引发的低血清症:一个病例报告
Bernard I Nkwocha1, Meenu Singh1
1Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, USA.
对于前列腺癌,阿比拉的处方正在增加. 本案例报告详细介绍了由abiraterone诱导的低血清症,强调密切监测电解质以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 内分泌学 在内分泌学.
背景情况:
- 阿比拉乙酸是一种FDA批准的雄激素生物合成抑制剂,用于转移性割抵抗性前列腺癌.
- 由于人口老龄化和前列腺癌与年龄相关,阿比拉的处方率有所增加.
- 了解阿比拉的副作用对于优化患者护理至关重要.
研究的目的:
- 描述由阿比拉诱导的低血清症的机制,临床表现和管理.
- 为了强调在接受阿比拉治疗的患者中保持警的电解质监测的重要性.
主要方法:
- 一个67岁的前列腺癌男性患者的病例报告.
- 对阿比拉的作用机制进行分析,从而导致电解质失衡.
- 对低血的临床表现和管理策略的审查.
主要成果:
- 该病例报告详细介绍了一名前列腺癌患者的阿比拉诱导的低血清症.
- 这项研究突出了与阿比拉治疗相关的特定不良影响概况.
- 有效的管理需要密切监测和纠正电解质水平.
结论:
- 阿比拉激素诱导的低血是一种需要医疗照顾的显著不良影响.
- 医生必须警监测abiraterone治疗的患者的电解质水平.
- 低血的积极管理对于患者的安全性和治疗疗效至关重要.
更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
相关概念视频
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Antihypertensive Drugs: Potassium-Sparing Diuretics
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
